Skip to main content
Clinical Trials/NCT04504773
NCT04504773
Completed
Not Applicable

Virtually Better: Using Immersive Virtual Reality to Treat Pediatric Anxiety

Johns Hopkins University1 site in 1 country3 target enrollmentSeptember 17, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Specific Phobia
Sponsor
Johns Hopkins University
Enrollment
3
Locations
1
Primary Endpoint
Clinical Severity Rating (CSR) of Targeted Specific Phobia on Anxiety Disorder Interview Schedule for Children and Parents (ADIS-C/P)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's office (e.g., heights, public speaking, storms). This poses a logistical challenge in treatment that: (1) takes time away from patient care, (2) leads clinicians to rely on imagined exposures, and/or (3) requires families to complete exposures outside of the therapy visits. This creates a burden for clinicians and families, and impedes treatment success. Immersive virtual reality (VR) presents an innovative solution that allows children to face fears without leaving the clinician's office. While VR has been used to distract children during painful medical procedures, it has not been well examined as a primary treatment for pediatric anxiety. This study proposes to examine the effectiveness and acceptability of using immersive VR exposures to treat children and adolescents with specific phobias.

Registry
clinicaltrials.gov
Start Date
September 17, 2020
End Date
February 14, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 8-17 years (inclusive),
  • meet diagnostic criteria for one or more phobias on a structured diagnostic interview (ADIS-C/P). This specifically includes natural environments (e.g., storms, heights) and/or situational settings (e.g., airplanes, public speaking).
  • be fluent in English.

Exclusion Criteria

  • unable to complete rating scales, or
  • attend study visits.

Outcomes

Primary Outcomes

Clinical Severity Rating (CSR) of Targeted Specific Phobia on Anxiety Disorder Interview Schedule for Children and Parents (ADIS-C/P)

Time Frame: 1 week after virtual reality exposure therapy session

The ADIS-C/P CSR for the Specific Phobia is a single item rating that is made by a clinician. Scores are made on a 9-point scale that ranges from 0 (Not at all) to 8 (Very, very much). A score of 4 or greater considered to be indicative of a psychiatric disorder.

Secondary Outcomes

  • Screen for Childhood Anxiety and Related Disorders-Parent Report (SCARED-P)(1 week after virtual reality exposure therapy session)

Study Sites (1)

Loading locations...

Similar Trials